New study reveals hundreds of new drug targets to combat tuberculosis

Immune cell linked to better lung cancer survival
30 May 2022
First genomic sequencing of monkeypox from Switzerland is now available
30 May 2022

New study reveals hundreds of new drug targets to combat tuberculosis

Tuberculosis is a stubborn disease, born of yet more stubborn microbes. While many bacterial infections resolve within days of starting antibiotics, tuberculosis often refuses to budge for around six months, and in some cases, may never release its vice grip on the human body. It claimed 1.5 million lives in 2020, second only to COVID-19 among infectious diseases.

Comments are closed.